|
Volumn 36, Issue 4, 2004, Pages 1090-1092
|
Portal enteric-drained solitary pancreas transplantation without surveillance biopsy: Is it safe?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PANCREAS ENZYME;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ADOLESCENT;
ADULT;
ARTERY THROMBOSIS;
CHRONIC GRAFT REJECTION;
CONFERENCE PAPER;
FOLLOW UP;
GRAFT REJECTION;
GRAFT SURVIVAL;
HLA MATCHING;
HUMAN;
HYPERACUTE GRAFT REJECTION;
IMMUNOSUPPRESSIVE TREATMENT;
ISCHEMIA;
LAPAROTOMY;
PANCREAS BIOPSY;
PANCREAS CANCER;
PANCREAS FUNCTION;
PANCREAS TRANSPLANTATION;
PORTAL ENTERIC DRAINED SOLITARY PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
RECIPIENT;
SAFETY;
SCHOOL CHILD;
SURGICAL DRAINAGE;
SURVIVAL RATE;
BIOPSY;
DRAINAGE;
HUMANS;
PANCREAS TRANSPLANTATION;
PORTAL SYSTEM;
REOPERATION;
RETROSPECTIVE STUDIES;
SAFETY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
EID: 20844439204
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.04.015 Document Type: Conference Paper |
Times cited : (7)
|
References (19)
|